| Financial Year |
March 31 2023 |
| Monetary Funds |
4,620,549,540.13 |
| Held-for-trading Financial Assets |
34,000,000.00 |
| Notes Receivable |
473,658,871.24 |
| Accounts Receivable |
5,305,689,926.87 |
| Advances to Suppliers |
902,885,167.71 |
| Other Receivables |
352,419,936.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
69,400,014.62 |
| Inventories |
838,762,310.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
91,857,140.28 |
| Other Current Assets |
141,720,073.39 |
| Total Current Assets |
18,689,849,413.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
826,459,220.29 |
| Investment Properties |
398,754,765.76 |
| Fixed Assetes |
4,385,169,126.60 |
| Under-construction Projects |
357,483,166.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
451,808,970.98 |
| R&D expenses |
-- |
| Goodwill |
571,723,661.57 |
| Long-Term Deferred and Prepaid Expenses |
83,338,819.23 |
| Deferred Income Tax Assets |
215,140,320.44 |
| Other Non-Current Assets |
78,911,181.29 |
| Sub-Total of Non-Current Assets |
8,557,642,966.23 |
| Total Assets |
27,247,492,379.69 |
| Short-Term Loans |
3,704,971,763.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,904,723,116.06 |
| Accounts Payable |
7,748,709,080.10 |
| Accounts Received In Advance |
18,966,666.69 |
| Employee Compensation Payable |
198,875,307.17 |
| Taxes Payable |
65,754,685.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
358,449,622.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
912,571,866.44 |
| Other Current Liabilities |
99,742,083.44 |
| Sub-Total of Current Liabilities |
17,545,460,354.37 |
| Long-term Loans |
1,369,580,606.96 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
118,408,215.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,671,294,439.08 |
| Total Liabilities |
19,216,754,793.45 |
| Paid-In Capital(Or Share Stock) |
2,106,190,178.00 |
| Capital Surplus |
3,145,482,915.21 |
| Surplus Reserve |
249,577,341.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,377,574,074.52 |
| Minority Stockholder's Interest |
766,596,372.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,264,141,213.54 |
| Owner's Equity（Stockholder's Equity） |
8,030,737,586.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
27,247,492,379.69 |
